Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State

British Journal of Biomedical Science

Volumn 70, Issue 4, 2013, Pages 156-160

  Bali, N K ^a   Fomda, B A ^a   Bashir, H ^a   Zahoor, D ^a   Lone, S ^a   Koul, Parvaiz A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acinetobacter; Carbapenemase; Carbapenems; Drug resistance, microbial

Indexed keywords

CARBAPENEMASE; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; PRIMER DNA;

ACINETOBACTER; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER; CHILD; CLIMATE; DISK DIFFUSION; EPSILOMETER TEST; HUMAN; INDIA; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; TRAVEL; DIFFUSION; DRUG EFFECT; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; YOUNG ADULT;

ACINETOBACTER; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DIFFUSION; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84893184282     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2013.11669950     Document Type: Article

References (29)

1. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5 (12): 939-51. (Pubitemid 350131182)
2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21 (3): 538-82.
3. Tsakris A, Ikonomidis A, Poulou A et al. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect 2008; 14 (6): 588-94. (Pubitemid 351639074)
4. Sunenshine RH, Wright MO, Maragakis LL et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 2007; 13 (1): 97-103. (Pubitemid 46057843)
5. Poirel L, Nordman P. Carbapenem resistance in Acinetobacter baunannii: mechanism and epidemiology. Clin Microbiol Infect 2006; 12 (9): 826-36. (Pubitemid 44151282)
6. Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006; 57 (3): 373-83. (Pubitemid 43240190)
7. Mostachio AK, van der Heidjen IV, Rossi F, Levin AS, Costa SF. Multiplex PCR for rapid detection of genes encoding OXA and metallo-beta-lactamases in carbapenem resistant Acinetobacter spp. J Med Microbiol 2009; 58 (Pt 11):1552-4.
8. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997; 35 (11): 2819-25. (Pubitemid 27452417)
9. Lone R, Shah A, Kadri SM, Lone S, Shah F. Nosocomial multidrug-resistant Acinetobacter infections - clinical findings, risk factors and demographic characteristics. Bangladesh J Med Microbiol 2009; 3 (1): 34-8 (www.banglajol.info/index.php/BJMM/ article/view/2969).
10. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Guidelines for the collection, transport, processing, analysis and reporting of cultures from specific specimen sources. In: Color Atlas and Textbook of Diagnostic Microbiology 6th edn. Philadelphia: Lippincott, Williams and Wilkins, 2006: 68-105.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement. CLSI Document M100-S20. Wayne, PA:CLSI, 2010.
12. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamases producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40 (10): 3798-801.
13. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double disk synergy test for differentiation of metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41 (10): 4623-9. (Pubitemid 37259767)
14. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J Clin Microbiol 2002; 40 (8): 2755-9. (Pubitemid 35284937)
15. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51 (10): 3471-84. (Pubitemid 47519332)
16. Su CH, Wang JT, Hsiung CA et al. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012; 7 (5): e37788.
17. Chu YW, Leung CM, Houang ET et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999; 37 (9): 2962-7. (Pubitemid 29391917)
18. Pandya NP, Prajapati SB, Mehta SJ, Kikani KM, Joshi PJ. Evaluation of various methods for MBL production in Gramnegative bacilli. Int J Biol Med Res 2011; 2 (3): 775-7.
19. Aybey AD, Aksit F, Oz Y, Kiremitci A, Durmaz G. Evaluation of an automated system for the detection of carbapenem-resistant Acinetobacter baumannii and assessment of metallo-β-lactamase production using two different phenotyping methods. J Microbiol Methods 2011; 86 (1): 121-3.
20. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States. Microb Drug Resist 2010; 16 (3): 209-15.
21. Anupurba S, Sen MR. Antimicrobial resistance profile of bacterial isolates from intensive care unit: changing trends. J Commun Dis 2005; 37 (1): 58-65. (Pubitemid 43531941)
22. Koh TS, Sng LH, Wang GC, Hsu LY, Zhao Y. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother 2007; 59 (4): 627-32. (Pubitemid 47073394)
23. Andriamanantena TS, Rastsima E, Rakotonirina HC et al. Dissemination of multidrug-resistant Acinetobacter baumannii in various hospitals in Antananarivo Madagascar. Ann Clin Microbiol Antimicrob 2010; 9: 17.
24. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, 24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SEBTRY Surveillance Program. J Antimicrob Chemother 2009; 63 (1): 55-9.
25. Sung JY, Kwon KC, Park JW et al. Dissemination of IMP-1 and OXA type-lactamase in carbapenam resistant Acinetobacter baumannii (in Korean). Korean J Lab Med 2008; 28 (1): 16-23.
26. Amudhan SM, Sekar U, Arunagiri K, Sekar B. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol 2011; 29 (3): 269-74.
27. Karunasagar A, Maiti B, Shekar M, Shenoy MS, Karunasagar I. Prevalance of OXA-type carbapenemase genes and genetic heterogeneity in clinical isolates of Acinetobacter spp. from Mangalore, India. Microbiol Immunol 2011; 55 (4): 239-46.
28. Susan B, Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 2006; 57 (1): 1-3. (Pubitemid 43057051)
29. Yang HY, Lee HJ, Suh JT, Lee KM. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23β-lactamases in a tertiary care hospital in Korea. Yonsei Med J 2009; 50 (6): 764-70.